Follow
Dr. Ramanaiah Chennuru
Dr. Ramanaiah Chennuru
Associate director & Head for COE Polymorphism and Crystallization (Physical R&D) at Cipla Ltd.,
Verified email at cipla.com
Title
Cited by
Cited by
Year
Effect of alkaline ultrasonic pretreatment on crystalline morphology and enzymatic hydrolysis of cellulose
G SriBala, R Chennuru, S Mahapatra, R Vinu
Cellulose 23, 1725-1740, 2016
712016
Improving solubility of poorly soluble abiraterone acetate by cocrystal design aided by in silico screening
R Chennuru, R Devarapalli, P Rengaraj, PL Srinivas, S Dey, CM Reddy
Crystal Growth & Design 20 (8), 5018-5030, 2020
272020
Iso-structurality induced solid phase transformations: a case study with lenalidomide
R Chennuru, P Muthudoss, RS Voguri, S Ramakrishnan, P Vishweshwar, ...
Crystal Growth & Design 17 (2), 612-628, 2017
242017
Investigation of poor solubility of a salt-cocrystal hydrate: A case study of the common-ion effect in Betrixaban, an anticoagulant drug
R Devarapalli, A Indukuri, M Bollineni, A Mondal, CM Reddy, R Chennuru
Molecular Pharmaceutics 18 (3), 1138-1149, 2021
212021
In situ metastable form: a route for the generation of hydrate and anhydrous forms of ceritinib
R Chennuru, RT Koya, P Kommavarapu, SV Narasayya, P Muthudoss, ...
Crystal Growth & Design 17 (12), 6341-6352, 2017
152017
Preliminary studies on unusual polymorphs of thymine: Structural comparison with other nucleobases
R Chennuru, P Muthudoss, S Ramakrishnan, AB Mohammad, RRC Babu, ...
Journal of Molecular Structure 1120, 86-99, 2016
132016
Polymorphs of Dasatinib
DR Rao, G Malhotra, SL Pathi, R Puppala, Y Jagannadham, R Chennuru
US Patent App. 16/344,952, 2019
72019
Polymorphic forms of nilotinib hydrochloride
V Peddy, R Chennuru, S Ramakrishnan
US Patent 9,580,408, 2017
62017
Novel solid forms of insomnia drug suvorexant with improved solubility and dissolution: accessing salts from a salt solvate route
S Gundlapalli, R Devarapalli, RR Mudda, R Chennuru, R Rupakula
CrystEngComm 23 (44), 7739-7749, 2021
52021
Polymorphic forms of nilotinib hydrochloride
V Peddy, R Chennuru, S Ramakrishnan
US Patent 9,981,947, 2018
42018
Synthesis, Structural and Theoretical Analyses of C≡ N··· I Halogen-Bonded Liquid Crystalline Complexes of 4-Cyano-4′-alkoxy Biphenyl Systems
KS Ingle, KM Bairagi, JS Thakur, R Sathishkumar, R Chennuru, B Baishya, ...
Crystal Growth & Design 23 (3), 1755-1767, 2023
22023
Polymorphs of ibrutinib
V Peddy, DJR Velaga, SL Kanniah, R Chennuru, S Ramakrishnan, ...
US Patent App. 15/553,559, 2018
22018
Novel salts of nilotinib and polymorphic forms thereof
SL Pathi, R Chennuru, R Puppala, R Barla, K Raghavendra
US Patent App. 17/798,742, 2023
12023
Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties
VN Saladi, BR Kammari, A Maruthapillai, S Mahapatra, R Chennuru, ...
ACS omega 7 (8), 7032-7044, 2022
12022
Crystal structure of 3-bromoacetyl-6-chloro-2H-1-benzopyran-2-one
R Chennuru, B Maddimsetti, S Gundlapalli, RRC Babu, S Mahapatra
Acta Crystallographica Section E: Crystallographic Communications 71 (8 …, 2015
12015
A zwitterionic salt–cocrystal: in vitro insights from niraparib tosylate, an anti-cancer drug
RR Mudda, R Devarapalli, A Das, PR Lakkireddy, CM Reddy, ...
CrystEngComm, 2024
2024
Methods for the preparation of sphingosine 1-phosphate receptor modulators and solid forme thereof
SL Pathi, PR Kumar, R Chennuru, DSN Yarra, Y Jagannadham, ...
US Patent App. 18/000,121, 2023
2023
Synthesis and Structural and Theoretical Analyses of CN center dot center dot center dot I Halogen-Bonded Liquid Crystalline Complexes of 4-Cyano-4'-alkoxy Biphenyl Systems
KS Ingle, KM Bairagi, JS Thakur, R Sathishkumar, R Chennuru, B Baishya, ...
CRYSTAL GROWTH & DESIGN, 2023
2023
Novel polymorphs of integrase inhibitor
VS Pullela, SL Pathi, R Chennuru, MS Phull, A Indukari
US Patent App. 17/429,438, 2022
2022
Polymorphic forms of ibrutinib
R Chennuru, SL Pathi, G Malhotra, R Devarapalli
US Patent App. 17/052,226, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20